Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Family Medicine
Disease Category: Angina
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

Stem Cell Study for Patients with Refractory Angina and Chronic Myocardial Ischemia

Purpose

If you are currently on the maximum tolerated dosage of your medication, and still experiencing symptoms of angina and myocardial ischemia, you’re invited to see if you may qualify for the Renew Study. The purpose of the study is to determine the safety and effectiveness of an investigational therapy using a patient’s own stem cells for the treatment of angina symptoms.

Each individual must be 21 or older, and will be evaluated to determine his or her eligibility. Qualified participants will receive either the investigational therapy or placebo, or continue with current approved angina treatment options, providing researchers with a standard comparison to the investigational therapy.

All participants will receive study-related medical exams and lab tests at no charge. Compensation for time and travel will be provided.

Other protocol specific inclusion/exclusion criteria apply

To Learn more
Phase

3

Gender

Both Male and Female

Age

21 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Cardiology Research Associates
305 Memorial Medical Parkway, Suite 301
Daytona Beach, FL 32117
Phone: 386-677-6672

View Map

Research Center Information: Cardiology Research Associates

CW ID: 182979

Date Last Changed: July 18, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.